ArticleFrontiers in oncology2026

Subsite-specific benefit of induction chemoimmunotherapy in HPV-negative oropharyngeal squamous cell carcinoma.

Lin Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.